National Bank Of Canada Amarin Corp Plcuk Transaction History

National Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$0.63 - $1.07 $504 - $856	-800 Reduced 66.67%	400 $0
Q1 2024 May 13, 2024	SELL	$0.82 - $1.35 $1,640 - $2,700	-2,000 Reduced 62.5%	1,200 $1,000
Q4 2023 Feb 06, 2024	BUY	$0.66 - $0.91 $594 - $819	900 Added 39.13%	3,200 $2,000
Q4 2021 Jan 24, 2022	BUY	$3.24 - $5.18 $7,452 - $11,914	2,300 New	2,300 $8,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.